bpc-157 fda warning not approved peptide safety BPC 157 Banned: Key Facts on the Latest Decision FDA panel narrowly backs unapproved

PMC 11070694

Potential vitamin D3 injection side effects include: Nausea Vomiting Headaches Constipation Growth problems (in children supplementing vitamin D) Poor appetite or loss of appetite Confusion Fever Decreased sex drive Mood changes Irregular, fast, or slow heartbeat Dry mouth or a metallic taste Disorientation or dizziness Kidney damage Increase in thirst Weight loss Weakness Sleepiness Edema, which is swelling of the ankles, feet, or hands Bone, joint, or muscle pain Vitamin D3 Injections While there are options to supplement vitamin D naturally through food or increased exposure to sunlight, it can also be orally ingested as a pill and injected

July Booking Incentive *Valid on treatments and retail products purchased July 131, 2026

RPL Peptide supports bulk supply, OEM packaging, private labeling, custom packaging, and long-term manufacturing partnerships for qualified research procurement

Focus on quality indicators rather than price alone

Potential Benefits: Dihexa is being investigated for its potential to: Improve cognitive function